Chordia Therapeutics Reports January

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure from was processed by Pulse News Wire on February 2, 2026. It represents a primary source document for Japanese Corporate sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

Chordia Therapeutics Reports January Exercise Status of Ninth Tranche Warrant

Source disclosure: February 02, 2026 Chordia Therapeutics Inc. [190A.T] TOKYO, Feb 02 (Pulse News Wire) – Chordia Therapeutics Inc. (190A.T) reported the exercise status of its ninth tranche warrant for January 2026. A total of 1,760,000 shares were delivered during the month, representing 17.05% of the outstanding warrants. As of the end of January, there were 67,009 unexercised warrants remaining. Exercise activities occurred on several dates throughout January, with notable trans